학술논문
Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial
Document Type
Article
Author
Ringshausen, F.C.; Shapiro, A.J.; Nielsen, K.G.; Mazurek, H.; Pifferi, M.; Donn, K.H.; van der Eerden, M.M.; Loebinger, M.R.; Zariwala, M.A.; Leigh, M.W.; Ferkol, T.W.; Knowles, M.R.; Ferkol, T.W.; Brown, T.; Carroll, M.; Church, N.; Couluris, M.; Davis, S.D.; Dell, S.D.; Di Cicco, M.E.; Di Mango, A.; Escobar, H.; Griffiths, A.; Haver, K.; Hornick, D.; Johnson, C.; Milla, C.E.; O'Donnell, A.; Pink, I.; Pogorzelski, A.; Prickett, M.; Raby, B.A.; Rosenfeld, M.; Saba, T.G.; Sandvik, R.M.; Sagel, S.D.; Salathe, M.; Simmons, A.E.; Solomon, G.M.; Sommerburg, O.; Soussi, N.; Strausbaugh, S.D.; Sullivan, K.M.; Werner, C.
Source
In: The Lancet Respiratory Medicine . (The Lancet Respiratory Medicine, January 2024, 12(1):21-33)
Subject
Language
English
ISSN
22132619
22132600
22132600